首页 > 最新文献

Medicina Clinica Practica最新文献

英文 中文
Vesícula en porcelana: Cuando la vesícula biliar se convierte en una obra de arte patológica
Q4 Medicine Pub Date : 2025-02-07 DOI: 10.1016/j.mcpsp.2024.100484
Alejandro del Caño Garrido , María Gómez Caballero
{"title":"Vesícula en porcelana: Cuando la vesícula biliar se convierte en una obra de arte patológica","authors":"Alejandro del Caño Garrido , María Gómez Caballero","doi":"10.1016/j.mcpsp.2024.100484","DOIUrl":"10.1016/j.mcpsp.2024.100484","url":null,"abstract":"","PeriodicalId":36921,"journal":{"name":"Medicina Clinica Practica","volume":"8 2","pages":"Article 100484"},"PeriodicalIF":0.0,"publicationDate":"2025-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143327681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Eficacia y seguridad del tratamiento con la combinación fija a dosis bajas de cinarizina 20 mg y dimenhidrinato 40 mg en el vértigo de origen diverso en la práctica clínica en España. Resultados del estudio VERTINEL
Q4 Medicine Pub Date : 2025-02-05 DOI: 10.1016/j.mcpsp.2024.100489
Rafael Hijano-Esqué , Jesús Ignacio González Orodea , Javier Imaz Fandos , Natividad Pacheco Rubio , Gonzalo Daniel Alzuarte , Manuel Ruiz Cuetos , Amelia Rodríguez Mariblanca , Eva García Aguilar , En representación del grupo de investigación VERTINEL

Introduction

Vertigo is a condition affecting millions of people and significantly impacting their quality of life. Traditionally, vertigo management includes the use of antiemetics, vestibular sedatives, and betahistine, though these treatments have limitations and side effects. The aim of this study was to evaluate the efficacy and safety of a low-dose fixed combination of cinnarizine 20 mg and dimenhydrinate 40 mg in routine clinical practice.

Methods

An observational, multicenter study was conducted, comprising a primary retrospective cohort and a cross-sectional cohort as a control group, across 28 Primary Care centers and Otolaryngology specialist clinics nationwide in Spain. Adult patients with vertigo of various origins treated with the fixed low-dose combination of cinnarizine 20 mg and dimenhydrinate 40 mg were included, and compared with a control group without treatment. Efficacy was assessed using the Vertigo and Dizziness Symptom Questionnaire (VDI-SS), and quality of life was evaluated through the VDI-HRQoL. Additional outcomes such as speed of action, tolerability, and treatment satisfaction were also measured.

Results

A total of 181 patients were analyzed, showing significant improvement in vertigo symptoms and quality of life in those treated with the drug combination compared to both pre-treatment and control groups. The pre-post treatment difference was 28.41 points on the VDI-SS questionnaire, p < 0.0001. Additionally, the difference between the post-treatment group and the control group was 24.07 points in favor of the treated group; 20.26 (95% CI 18.8–21.7) vs. 44.33 (95% CI 42.6–46), p < 0.0001. In quality-of-life assessments, the mean difference was 14.56 points between pretreatment and post-treatment, p < 0.0001, with a similar result observed in comparison with the control group, p < 0.0001. Improvement was reported by 78.3% (65) of treated subjects within the first week, with 55.4% reporting benefits in the first few days of treatment, and reaching 89.1% by the second week. Tolerability was rated as very good or good in most cases, with no serious adverse events reported, and no extrapyramidal effects, drowsiness, or inhibition of vestibular compensation mechanisms were noted. Overall treatment satisfaction was high.

Discussion

The results confirm the efficacy and safety of the low-dose fixed combination of cinnarizine 20 mg and dimenhydrinate 40 mg in vertigo treatment. This therapeutic approach not only addresses specific vertigo symptoms but also improves patients' quality of life. Its rapid onset of action, along with high tolerability and satisfaction, supports the viability of this intervention in routine clinical practice, offering an effective and safe alternative for managing vertigo.
{"title":"Eficacia y seguridad del tratamiento con la combinación fija a dosis bajas de cinarizina 20 mg y dimenhidrinato 40 mg en el vértigo de origen diverso en la práctica clínica en España. Resultados del estudio VERTINEL","authors":"Rafael Hijano-Esqué ,&nbsp;Jesús Ignacio González Orodea ,&nbsp;Javier Imaz Fandos ,&nbsp;Natividad Pacheco Rubio ,&nbsp;Gonzalo Daniel Alzuarte ,&nbsp;Manuel Ruiz Cuetos ,&nbsp;Amelia Rodríguez Mariblanca ,&nbsp;Eva García Aguilar ,&nbsp;En representación del grupo de investigación VERTINEL","doi":"10.1016/j.mcpsp.2024.100489","DOIUrl":"10.1016/j.mcpsp.2024.100489","url":null,"abstract":"<div><h3>Introduction</h3><div>Vertigo is a condition affecting millions of people and significantly impacting their quality of life. Traditionally, vertigo management includes the use of antiemetics, vestibular sedatives, and betahistine, though these treatments have limitations and side effects. The aim of this study was to evaluate the efficacy and safety of a low-dose fixed combination of cinnarizine 20 mg and dimenhydrinate 40 mg in routine clinical practice.</div></div><div><h3>Methods</h3><div>An observational, multicenter study was conducted, comprising a primary retrospective cohort and a cross-sectional cohort as a control group, across 28 Primary Care centers and Otolaryngology specialist clinics nationwide in Spain. Adult patients with vertigo of various origins treated with the fixed low-dose combination of cinnarizine 20 mg and dimenhydrinate 40 mg were included, and compared with a control group without treatment. Efficacy was assessed using the Vertigo and Dizziness Symptom Questionnaire (VDI-SS), and quality of life was evaluated through the VDI-HRQoL. Additional outcomes such as speed of action, tolerability, and treatment satisfaction were also measured.</div></div><div><h3>Results</h3><div>A total of 181 patients were analyzed, showing significant improvement in vertigo symptoms and quality of life in those treated with the drug combination compared to both pre-treatment and control groups. The pre-post treatment difference was 28.41 points on the VDI-SS questionnaire, <em>p</em> &lt; 0.0001. Additionally, the difference between the post-treatment group and the control group was 24.07 points in favor of the treated group; 20.26 (95% CI 18.8–21.7) vs. 44.33 (95% CI 42.6–46), <em>p</em> &lt; 0.0001. In quality-of-life assessments, the mean difference was 14.56 points between pretreatment and post-treatment, <em>p</em> &lt; 0.0001, with a similar result observed in comparison with the control group, <em>p</em> &lt; 0.0001. Improvement was reported by 78.3% (65) of treated subjects within the first week, with 55.4% reporting benefits in the first few days of treatment, and reaching 89.1% by the second week. Tolerability was rated as very good or good in most cases, with no serious adverse events reported, and no extrapyramidal effects, drowsiness, or inhibition of vestibular compensation mechanisms were noted. Overall treatment satisfaction was high.</div></div><div><h3>Discussion</h3><div>The results confirm the efficacy and safety of the low-dose fixed combination of cinnarizine 20 mg and dimenhydrinate 40 mg in vertigo treatment. This therapeutic approach not only addresses specific vertigo symptoms but also improves patients' quality of life. Its rapid onset of action, along with high tolerability and satisfaction, supports the viability of this intervention in routine clinical practice, offering an effective and safe alternative for managing vertigo.</div></div>","PeriodicalId":36921,"journal":{"name":"Medicina Clinica Practica","volume":"8 2","pages":"Article 100489"},"PeriodicalIF":0.0,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143327680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dermatomiositis clínicamente amiopática: primer signo de cáncer gástrico
Q4 Medicine Pub Date : 2025-01-31 DOI: 10.1016/j.mcpsp.2024.100490
Nayi Xiomara Duque Alvarez , María del Mar Blanes Martínez , Jose M. Ramia Ángel , Silvia Carbonell-Morote
{"title":"Dermatomiositis clínicamente amiopática: primer signo de cáncer gástrico","authors":"Nayi Xiomara Duque Alvarez ,&nbsp;María del Mar Blanes Martínez ,&nbsp;Jose M. Ramia Ángel ,&nbsp;Silvia Carbonell-Morote","doi":"10.1016/j.mcpsp.2024.100490","DOIUrl":"10.1016/j.mcpsp.2024.100490","url":null,"abstract":"","PeriodicalId":36921,"journal":{"name":"Medicina Clinica Practica","volume":"8 2","pages":"Article 100490"},"PeriodicalIF":0.0,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143162998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severe mitral stenosis masquerading as malar rash
Q4 Medicine Pub Date : 2025-01-29 DOI: 10.1016/j.mcpsp.2025.100491
Ana Rita Teixeira, Luís Almeida Morais, Rui Cruz Ferreira
{"title":"Severe mitral stenosis masquerading as malar rash","authors":"Ana Rita Teixeira,&nbsp;Luís Almeida Morais,&nbsp;Rui Cruz Ferreira","doi":"10.1016/j.mcpsp.2025.100491","DOIUrl":"10.1016/j.mcpsp.2025.100491","url":null,"abstract":"","PeriodicalId":36921,"journal":{"name":"Medicina Clinica Practica","volume":"8 2","pages":"Article 100491"},"PeriodicalIF":0.0,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143163001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Infiltrado linfocítico de Jessner asociado a lupus eritematoso sistémico con lesiones cutáneas atípicas
Q4 Medicine Pub Date : 2025-01-23 DOI: 10.1016/j.mcpsp.2024.100488
Hilayali Aguilar-Molina , Daniel Manzur-Sandoval
{"title":"Infiltrado linfocítico de Jessner asociado a lupus eritematoso sistémico con lesiones cutáneas atípicas","authors":"Hilayali Aguilar-Molina ,&nbsp;Daniel Manzur-Sandoval","doi":"10.1016/j.mcpsp.2024.100488","DOIUrl":"10.1016/j.mcpsp.2024.100488","url":null,"abstract":"","PeriodicalId":36921,"journal":{"name":"Medicina Clinica Practica","volume":"8 2","pages":"Article 100488"},"PeriodicalIF":0.0,"publicationDate":"2025-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143162997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neumonía por COVID-19 en urgencias: ecografía pulmonar. Implicaciones pronósticas
Q4 Medicine Pub Date : 2025-01-23 DOI: 10.1016/j.mcpsp.2024.100486
Mónica Contreras-Moreira , Elpidio Calvo Manuel , Joaquín Antonio Álvarez Gregori

Introduction and objectives

In COVID-19 patients, the clinical picture allows estimating a certain pre-test probability of lung involvement; prediction that increases when associating lung ultrasound. This provides greater sensitivity than chest radiography in the detection of infiltrates, and makes it possible to predict the result of pathological pulmonary CT. The characteristic findings of SARS-CoV-2 pneumonia have been described, and the location of the lesions has been related to the prognosis. Few experiences have been published on the prognostic capacity of lung ultrasound, which do not include hospital-obtained laboratory parameters.

Material and methods

Through a prospective, multicenter, observational study with consecutive sampling, carried out between April and July 2020, 263 adult patients who attended the emergency department of Spanish hospitals due to symptoms compatible with respiratory infection were recruited. Six fields per lung were explored, and the presence or absence of focal B lines, global B lines, parenchymal consolidation, subpleural consolidation, and pleural effusion were described. The patients underwent a postero-anterior chest X-ray on the same day.

Results

Males predominated in the study population. The main comorbidity was neoplasms, followed by chronic kidney disease and ischemic heart disease. Patients with a positive result for SARS-CoV-2 RT-PCR and who required admission were more frequent, and 8% died. The pathological chest x-ray was positive in 75% of the patients, compared to 94.59% of the ultrasound scans. The most frequent findings were focal B lines in zones R6, R3, and L3. The specificity of bilateral consolidation or unilateral patchy infiltrate stands out, and in ultrasound the specificity of global B lines, consolidations, both pulmonary and subpleural, and left pleural effusion.

Conclusions

A regression model has been developed that incorporates the findings of the lung ultrasound and predicts the probability of admission in patients presenting to the emergency department, without using other hospital laboratory tests. A tool can be developed that allows the family physician to identify patients with a high probability of being hospitalized from those who will have an outpatient follow-up, to prioritize an early therapeutic approach or referral to the emergency room.
{"title":"Neumonía por COVID-19 en urgencias: ecografía pulmonar. Implicaciones pronósticas","authors":"Mónica Contreras-Moreira ,&nbsp;Elpidio Calvo Manuel ,&nbsp;Joaquín Antonio Álvarez Gregori","doi":"10.1016/j.mcpsp.2024.100486","DOIUrl":"10.1016/j.mcpsp.2024.100486","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>In COVID-19 patients, the clinical picture allows estimating a certain pre-test probability of lung involvement; prediction that increases when associating lung ultrasound. This provides greater sensitivity than chest radiography in the detection of infiltrates, and makes it possible to predict the result of pathological pulmonary CT. The characteristic findings of SARS-CoV-2 pneumonia have been described, and the location of the lesions has been related to the prognosis. Few experiences have been published on the prognostic capacity of lung ultrasound, which do not include hospital-obtained laboratory parameters.</div></div><div><h3>Material and methods</h3><div>Through a prospective, multicenter, observational study with consecutive sampling, carried out between April and July 2020, 263 adult patients who attended the emergency department of Spanish hospitals due to symptoms compatible with respiratory infection were recruited. Six fields per lung were explored, and the presence or absence of focal B lines, global B lines, parenchymal consolidation, subpleural consolidation, and pleural effusion were described. The patients underwent a postero-anterior chest X-ray on the same day.</div></div><div><h3>Results</h3><div>Males predominated in the study population. The main comorbidity was neoplasms, followed by chronic kidney disease and ischemic heart disease. Patients with a positive result for SARS-CoV-2 RT-PCR and who required admission were more frequent, and 8% died. The pathological chest x-ray was positive in 75% of the patients, compared to 94.59% of the ultrasound scans. The most frequent findings were focal B lines in zones R6, R3, and L3. The specificity of bilateral consolidation or unilateral patchy infiltrate stands out, and in ultrasound the specificity of global B lines, consolidations, both pulmonary and subpleural, and left pleural effusion.</div></div><div><h3>Conclusions</h3><div>A regression model has been developed that incorporates the findings of the lung ultrasound and predicts the probability of admission in patients presenting to the emergency department, without using other hospital laboratory tests. A tool can be developed that allows the family physician to identify patients with a high probability of being hospitalized from those who will have an outpatient follow-up, to prioritize an early therapeutic approach or referral to the emergency room.</div></div>","PeriodicalId":36921,"journal":{"name":"Medicina Clinica Practica","volume":"8 2","pages":"Article 100486"},"PeriodicalIF":0.0,"publicationDate":"2025-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143163000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Are hospital workers' healthy habits adequeate? Influence of social determinants on health
Q4 Medicine Pub Date : 2025-01-17 DOI: 10.1016/j.mcpsp.2024.100487
Claudia Ruiz-Huerta , Gema Vega , Carmen Ferrer , Marcelle V. Canto , María de los Ángeles Díaz , Ana M. Palmar

Introduction/objectives

With regard to people who work in hospitals: Do they have better health habits than the general population? Or, do they have worse, despite most of them have the appropriate knowledge to follow a healthy lifestyle? This is a study to explore the habits of people working in a hospital, to compare them with the general population and to identify higher risk profiles on which to prioritize preventive interventions.

Methods

Cross-sectional study on health habits with workers from a hospital in Madrid (n = 399) using a questionnaire based on the National Health Survey. Descriptive and cluster analysis to classify homogeneous individuals according to health habits and identify risk patterns. Logistic regression was used to identify the independent risk factors that determine the unhealthy profile.

Results

The health habits of workers in a hospital are similar to those of the general population. Determinants of health influenced its distribution: The higher the spending capacity, the better the health habits; the older their age, more chronic disease is seen; women suffer worse mental health.

Conclusions

The results are superimposed onto those of the general population, where they would have been expected to be healthier. There are risk profiles in which to prioritize preventive interventions to promote health.
{"title":"Are hospital workers' healthy habits adequeate? Influence of social determinants on health","authors":"Claudia Ruiz-Huerta ,&nbsp;Gema Vega ,&nbsp;Carmen Ferrer ,&nbsp;Marcelle V. Canto ,&nbsp;María de los Ángeles Díaz ,&nbsp;Ana M. Palmar","doi":"10.1016/j.mcpsp.2024.100487","DOIUrl":"10.1016/j.mcpsp.2024.100487","url":null,"abstract":"<div><h3>Introduction/objectives</h3><div>With regard to people who work in hospitals: Do they have better health habits than the general population? Or, do they have worse, despite most of them have the appropriate knowledge to follow a healthy lifestyle? This is a study to explore the habits of people working in a hospital, to compare them with the general population and to identify higher risk profiles on which to prioritize preventive interventions.</div></div><div><h3>Methods</h3><div>Cross-sectional study on health habits with workers from a hospital in Madrid (<em>n</em> = 399) using a questionnaire based on the National Health Survey. Descriptive and cluster analysis to classify homogeneous individuals according to health habits and identify risk patterns. Logistic regression was used to identify the independent risk factors that determine the unhealthy profile.</div></div><div><h3>Results</h3><div>The health habits of workers in a hospital are similar to those of the general population. Determinants of health influenced its distribution: The higher the spending capacity, the better the health habits; the older their age, more chronic disease is seen; women suffer worse mental health.</div></div><div><h3>Conclusions</h3><div>The results are superimposed onto those of the general population, where they would have been expected to be healthier. There are risk profiles in which to prioritize preventive interventions to promote health.</div></div>","PeriodicalId":36921,"journal":{"name":"Medicina Clinica Practica","volume":"8 2","pages":"Article 100487"},"PeriodicalIF":0.0,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143162993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Carcinoma of the ovary with metastasis to the cerebellum
Q4 Medicine Pub Date : 2025-01-01 DOI: 10.1016/j.mcpsp.2024.100483
Irma D. Sifuentes-Najera , Juan J. Cuervo-Orozco , Ma.G. Treviño-Alanís , María G. Moreno-Treviño , Gerardo Rivera-Silva
{"title":"Carcinoma of the ovary with metastasis to the cerebellum","authors":"Irma D. Sifuentes-Najera ,&nbsp;Juan J. Cuervo-Orozco ,&nbsp;Ma.G. Treviño-Alanís ,&nbsp;María G. Moreno-Treviño ,&nbsp;Gerardo Rivera-Silva","doi":"10.1016/j.mcpsp.2024.100483","DOIUrl":"10.1016/j.mcpsp.2024.100483","url":null,"abstract":"","PeriodicalId":36921,"journal":{"name":"Medicina Clinica Practica","volume":"8 1","pages":"Article 100483"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143134537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lóbulo de Riedel y hemangioma hepático
Q4 Medicine Pub Date : 2025-01-01 DOI: 10.1016/j.mcpsp.2024.100485
José Manuel Ramia , Cándido Alcázar , Celia Villodre , Silvia Carbonell-Morote
{"title":"Lóbulo de Riedel y hemangioma hepático","authors":"José Manuel Ramia ,&nbsp;Cándido Alcázar ,&nbsp;Celia Villodre ,&nbsp;Silvia Carbonell-Morote","doi":"10.1016/j.mcpsp.2024.100485","DOIUrl":"10.1016/j.mcpsp.2024.100485","url":null,"abstract":"","PeriodicalId":36921,"journal":{"name":"Medicina Clinica Practica","volume":"8 1","pages":"Article 100485"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143134536","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bowen's disease 博文氏病
Q4 Medicine Pub Date : 2024-11-29 DOI: 10.1016/j.mcpsp.2024.100482
María G. Moreno-Treviño , Julio C. Salas-Alanís , Mauricio Salas-Garza , Ma.G. Treviño-Alanís , David I. Orozco-Pasadas , Gerardo Rivera-Silva
{"title":"Bowen's disease","authors":"María G. Moreno-Treviño ,&nbsp;Julio C. Salas-Alanís ,&nbsp;Mauricio Salas-Garza ,&nbsp;Ma.G. Treviño-Alanís ,&nbsp;David I. Orozco-Pasadas ,&nbsp;Gerardo Rivera-Silva","doi":"10.1016/j.mcpsp.2024.100482","DOIUrl":"10.1016/j.mcpsp.2024.100482","url":null,"abstract":"","PeriodicalId":36921,"journal":{"name":"Medicina Clinica Practica","volume":"8 1","pages":"Article 100482"},"PeriodicalIF":0.0,"publicationDate":"2024-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142747150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Medicina Clinica Practica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1